Subject : | RE: RE: RE: RE: | MessageDate : | 5/19/2018 5:09:21 PM | Posted By : | Madeline | Email : | kenton6b@aol.com | Message : | We'll need to take up references http://opendataricostruzione.gssi.it/blog/index.php/stmap_e1ba0.html?lisinopril-hctz.selegiline.levitra medi-dyne.com/support.html The study suggests that characteristics at diagnosis explain the differences in survival, not differences in the type, duration and frequency of treatment. Black patients had poorer health at diagnosis, including more advanced disease, worse biological features of the disease, and larger tumor size.
***---REPLIED TO MESSAGE BELOW---*** We'll need to take up references http://opendataricostruzione.gssi.it/blog/index.php/stmap_e1ba0.html?lisinopril-hctz.selegiline.levitra medi-dyne.com/support.html The study suggests that characteristics at diagnosis explain the differences in survival, not differences in the type, duration and frequency of treatment. Black patients had poorer health at diagnosis, including more advanced disease, worse biological features of the disease, and larger tumor size.
|
Parent Message
RE: RE: RE: - Maurice (178) - 5/14/2018 6:13:47 AM
Replies
No Current Replies
Post A Reply To This Message
|
|